Related Experiment Video
Updated: Aug 11, 2026
10:39
A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
Published on: September 17, 2020
Genetics of aging: implications for drug discovery and development
1Elixir Pharmaceuticals, Cambridge, MA 02139, USA. geesaman@elixirpharm.com
The American Journal of Clinical Nutrition
|February 14, 2006
Summary
Aging is a regulated metabolic process influenced by genes and environment. Studying conserved pathways in model organisms reveals links between aging, metabolism, and diseases like diabetes, offering therapeutic targets.
Area of Science:
- Gerontology
- Metabolic Regulation
- Molecular Biology
Background:
- Aging is an active, genetically and environmentally influenced metabolic process.
- Human aging is complex to study directly; model organisms offer conserved insights.
- Metabolic pathways, including insulin-growth hormone signaling, are key to aging and longevity.
Purpose of the Study:
- To explore the molecular links between aging, metabolism, and age-related diseases.
- To investigate the potential of targeting conserved aging pathways for therapeutic interventions.
- To understand how metabolic dysregulation, like in diabetes, relates to accelerated aging.
Main Methods:
- Comparative analysis of aging pathways across species (yeast, worms, fruit flies, mammals).
- Examination of conserved molecular mechanisms regulating lifespan and metabolism.
- Investigating the relationship between glucose homeostasis, type 2 diabetes, and aging.
Main Results:
- Aging is a conserved, actively regulated metabolic process.
- Insulin-growth hormone signaling pathways are implicated in aging across diverse organisms.
- Dysregulated glucose homeostasis and type 2 diabetes resemble accelerated aging.
Conclusions:
- Aging and metabolic diseases like diabetes share common molecular underpinnings.
- Targeting conserved aging pathways could offer novel treatments for age-related diseases.
- Pharmacological modulation of aging pathways may prevent or treat a spectrum of diseases.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...